首页|基于直线加速器容积调强放射治疗多中心全脑全脊髓海马保护剂量学研究

基于直线加速器容积调强放射治疗多中心全脑全脊髓海马保护剂量学研究

扫码查看
目的 探讨基于直线加速器采用容积调强放射治疗(VMAT)技术实现多中心全脑全脊髓海马保护放射治疗可行性.方法 选择2021-01-01-2022-12-31广东医科大学附属医院肿瘤医院放疗中心完成手术及化疗后需行全脑全脊髓放射治疗且无病灶转移的9例患者作为研究对象.女5例,男4例.平均年龄(12.13±3.91)岁.每例患者计划设置2个放射治疗中心,分别设计标准VMAT(S-VMAT)计划和海马保护VMAT(HA-VMAT)计划,并进行计划评估及剂量学分析.t检验评估2种计划的均匀性指数(HI)、适形性指数(CI)、梯度指数(GI),计划靶体积(PTV)最大剂量(PTVmax)、平均剂量(PTVmean)、100%处方剂量体积占整个PTV体积比(V100%)以及海马等其他正常组织的剂量.结果 S-VMAT 计划 HI、CI、GI 分别为 0.06±0.02、0.97±0.05 和 2.15±0.23,相较于 HA-VMAT 计划的 0.11± 0.12、0.95±0.03和3.59±0.67,差异有统计学意义,t值分别为-3.568、-2.380和-5.421,P值分别为<0.001、0.032和<0.001;S-VMAT 计划 PTVmax、PTVmean、V100%分别为(39.07±1.00)Gy、(38.33±1.10)Gy 和(98.33± 1.12)%,与 HA-VMAT 计划的(41.00±0.33)Gy、(37.65±0.88)Gy 和(95.73±0.88)%比较,差异有统计学意义,t 值分别为-7.439、-2.312和-2.975,P值分别为0.003、0.033和0.035).S-VMAT计划海马最大和平均剂量分别为(38.51±0.48)和(37.59±0.29)Gy,HA-VMAT 计划为(14.88±0.34)和(9.74±0.24)Gy,差异有统计学意义,t 值分别为-4.432和-4.457,均P<0.001.S-VMAT计划的肝脏、气管、喉、口腔平均剂量低于HA-VMAT计划,差异有统计学意义,t 值分别为-3.008、-4.324、-2.901 和-3.325,P 值分别为 0.015、0.001、0.046 和 0.025;S-VMAT 计划的眼球最大剂量、平均剂量,以及右肾、胰腺的平均剂量高于HA-VMAT计划,差异有统计学意义,t值分别为-1.245、-1.689、1.592和5.122,P值分别为0.047、0.049、0.042和<0.001.结论 采用直线加速器VMAT多中心放射治疗技术,全脑全脊髓放射治疗时在保证靶区覆盖率、均匀性、适形性、高剂量跌落同时,能够减少海马体的剂量,从而实现患者认知功能的保护.
Dosimetric study of hippocampus avoidance in multi-center craniospinal irradiation based on volumetric modulated arc therapy with a linear accelerator
Objective To explore the feasibility of multicenter hippocampal-protected craniospinal radiotherapy using volu-metric modulated arc therapy(VMAT)based on a linear accelerator.Methods Nine patients who underwent surgery and chemotherapy at the Cancer Hospital of Affiliated Hospital of Guangdong Medical University from January 1,2022 to De-cember 31,2022,and were required to undergo whole brain and spinal cord radiation therapy without lesion metastasis,were selected as the study subjects.There were 5 females and 4 males.The average age was(12.13±3.91)years old.For each patient,two radiation treatment centers were planned,and standard VMAT(S-VMAT)plans and hippocampal-protected VMAT(HA-VMAT)plans were designed respectively.Plan evaluation and dose analysis were conducted for both types of plans.The t-test was used to evaluate the homogeneity index(HI),conformity index(CI),gradiend index(GI),the planned target volume(PTV)with maximum dose(PTVmax),mean dose(PTVmean),the proportion of 100%prescription dose to body PTV volume(V100%),and the dose to other normal tissues such as the hippocampus.Results The HI,CI,and GI value of the S-VMAT plan were 0.06±0.02,0.97±0.05,and 2.15±0.23,respectively,com-pared with the HA-VMAT plan's values of 0.11±0.12,0.95±0.03,and 3.59±0.67.The differences were statistically significant,with t-values of-3.568,-2.380,and-5.421,and P-values of<0.001,0.032,and<0.001,respective-ly.The PTVmax,PTVmean,and V100%values of the S-VMAT plan were(39.07±1.00)Gy,(38.33±1.10)Gy,and(98.33±1.12)%,respectively,compared with the HA-VMAT plan's values of(41.00±0.33)Gy,(37.65±0.88)Gy,and(95.73±0.88)%.The differences were statistically significant,with t-values of-7.439,-2.312,and-2.975,and P-values of 0.003,0.033,and 0.035,respectively.The maximum and average doses to the hippocampus in the S-VMAT plan were(38.51±0.48)and(37.59±0.29)Gy,respectively,while those in the HA-VMAT plan were(14.88±0.34)and(9.74±0.24)Gy.The differences were statistically significant,with the t-values were-4.432 and-4.457,respectively,with all P<0.001.The average doses to the liver,trachea,throat,and mouth of the S-VMAT plan was lower than those of the HA-VMAT plan.The differences were statistically significant,with the t-values were-3.008,-4.324,-2.901,and-3.325,respectively,with P-values of 0.015,0.001,0.046,and 0.025.The maxi-mum dose and average dose to the eyeball of the S-VMAT plan,as well as the average dose to the right kidney and pan-creas,were higher than those of the HA-VMAT plan.The differences were statistically significant,with the t-values were-1.245,-1.689,1.592,and 5.122,respectively,and the P-values were 0.047,0.049,0.042,and<0.001.Conclusion The use of linear accelerator VMAT multi center radiotherapy technology can reduce the dose to the hippo-campus while ensuring target coverage,homogeneity,conformability,and high-dose fall-off during whole brain and spinal cord radiotherapy,thereby achieving the protection of cognitive function in patients.

whole brain and spinal cord radiation therapyvolumetric modulated arc therapyhippocampus protectiondose

李伶、房诗婷、麦燕华、江丹贤、曾词正

展开 >

广东医科大学附属医院肿瘤医院放疗机房,广东湛江 524001

南方医科大学生物医学工程学院,广东广州 510515

广东医科大学附属医院儿童医学中心,广东湛江 524001

全脑全脊髓放射治疗 容积调强放射治疗 海马保护 剂量

湛江市非资助科技攻关计划广东医科大学科研项目

2022B01041GDMUM2019040

2024

社区医学杂志
中华预防医学会

社区医学杂志

影响因子:0.588
ISSN:1672-4208
年,卷(期):2024.22(5)
  • 21